DIASAGE (DIABETIC)
 (1).png)
LINASUG-DM 500
Composition:
Lingaliptin 5mg+Dapagliflozin 10mg+ Metformin Hcl (SR) 500mg/1000mg
Indication: Reduces the hepatic glucose uptake by 19%.
Indication: Reduces the hepatic glucose uptake by 19%.
LINASUG-M 5/500 Tab
Composition:
Linagliptin 5 mg and Metformin Hydrochloride (SR) 500 mg Tablets
Indication: Indicated as an adjunct to diet & exercise to improve glycemic Control in Adults with Type 2 Diabetes Mellitus
Indication: Indicated as an adjunct to diet & exercise to improve glycemic Control in Adults with Type 2 Diabetes Mellitus
VOGLISUG-RAPID TAB
Composition:
Repaglinide 1mg + Voglibose 0.3mg
Indication: Helps control blood sugar levels by stimulating insulin release and slowing carbohydrate absorption, thereby reducing post-meal blood glucose spikes.
Indication: Helps control blood sugar levels by stimulating insulin release and slowing carbohydrate absorption, thereby reducing post-meal blood glucose spikes.
TENISUG-PM TABS
Composition:
Teneligliptin 20mg +Pioglitazone 15mg + Metformin 500 MG (ER)
Indication: Used for the treatment of type 2 diabetes
Indication: Used for the treatment of type 2 diabetes
VOGLISUG-TRIO 0.3 Tablets
Composition:
Gliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg
Indication: Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
Indication: Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
VOGLISUG-TRIO 0.2 TABS
Composition:
Voglibose IP 0.2mg + Gliclazide IP 80mg + Metformin Hydrochloride IP 500mg
Indication: Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
Indication: Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
DAPASUG-GM-2 Tablet
Composition:
Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (As extended release form)
Indication: Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
Indication: Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
VOGLISUG-GM 3
Composition:
Voglibose 0.3mg + Glimepiride 2mg+ Metformin HCI 500mg
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-GM
Composition:
Voglibose 0.2mg + Glimepiride 2mg + Metformin HCL 500mg
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-0.3
Composition:
Voglibose 0.3mg (Mouth Dissolving)
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-0.2
Composition:
Voglibose 0.2mg (Mouth Dissolving)
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Indication: Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VIAMETA-500 SR
Composition:
Metformin Hydrochloride 500 (SR Form)
Indication: Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
Indication: Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
VIAMETA-1000 SR
Composition:
Metformin Hydrochloride 1000mg (SR Form)
Indication: Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
Indication: Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
TENISUG-PG
Composition:
Teneligliptin 20mg + Pioglitazone 15 mg
Indication: For adults with Uncontrolled Type 2 Diabetes.
Indication: For adults with Uncontrolled Type 2 Diabetes.
TENISUG-M 500
Composition:
Teneligliptin 20mg + Metformin Hydrochloride 500mg (Prolonged Release)
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
TENISUG-M 1000
Composition:
Teneligliptin 20mg + Metformin Hydrochloride 1000mg (Prolonged Release)
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
TENISUG-20
Composition:
Teneligliptin 20mg
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
Indication: Stage 2 Hypertension, Hypertension associated with diabetes.
TENIFIX-20
Composition:
Teneligliptin 20mg
Indication: As a monotherapy adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
Indication: As a monotherapy adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
SUGAVIA-M 500
Composition:
Sitagliptin 50mg + Metformin Hydrochloride IP 500mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAVIA-50
Composition:
Sitagliptin 50mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAVIA-100
Composition:
Sitagliptin 100mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAPILL-PIO
Composition:
Vildagliptin 50mg + Pioglitazone HCI 15mg
Indication: Type 2 Diabetes
Indication: Type 2 Diabetes
SUGAPILL-M 850
Composition:
Vildagliptin 50mg + Metformin 850mg Film Coated
Indication: Type-2 Diabetes
Indication: Type-2 Diabetes
SUGAPILL-M 500
Composition:
Vildagliptin 50mg + Metformin 500mg Film Coated
Indication: Type-2 Diabetes.
Indication: Type-2 Diabetes.
SUGAPILL-M 1000
Composition:
Vildagliptin 50mg + Metformin 1000mg Film Coated
Indication: Type-2 Diabetes
Indication: Type-2 Diabetes
SUGAMIDE-PM-2 NANO FAST Tabs
Composition:
Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg (In SR)
Indication: Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
Indication: Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
SUGAMIDE-PM-2
Composition:
Glimepiride 2mg +Pioglitazone 15mg + Metformin 500mg (In SR)
Indication: Type 2 Diabetes
Indication: Type 2 Diabetes
.png)
SUGAMIDE-PM-1
Composition:
Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg (In SR)
Indication: Type 2 Diabetes
Indication: Type 2 Diabetes
SUGAMIDE-M4 FORTE
Composition:
Glimepiride 4mg + Metformin 1000mg
Indication: Type 2 Diabetes
Indication: Type 2 Diabetes
SUGAMIDE-M3 FORTE
Composition:
Glimepiride 3mg + Metformin 1000mg
Indication: Type 2 Diabetes
Indication: Type 2 Diabetes
SUGAMIDE-M2 1000
Composition:
Glimepiride 2mg + Metformin 1000mg in SR
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-M2
Composition:
Glimepiride 2mg + Metformin 500mg (In SR)
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-M1 1000
Composition:
Glimepiride 1mg + metformin 1000mg in SR,
Indication:
Indication:
SUGAMIDE-M-2 NANO FAST Tabs
Composition:
Glimepiride 2mg + Metformin 500mg (In SR)
Indication: Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
Indication: Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
.png)
SUGAMIDE-M-1
Composition:
Glimepiride 1mg + Metformin 500mg (Bi Layer Tablet) (In SR)
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-2
Composition:
Glimepiride 2mg
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
Indication: Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGALIFE-M
Composition:
Gliclazide 80mg + Metformin 500mg
Indication: Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
Indication: Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
SUGALIFE-40
Composition:
Gliclazide 40mg
Indication: Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
Indication: Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
SITANOW-PM TABLETS
Composition:
Sitagliptin 100 mg + Pioglitazone Hydrochloride IP 15 mg + Metformin Hydrochloride IP 500 mg (As Sustained Release form)
Indication: For Type-II Diabetic Mellitus, Increases insulin secretion, Improves B-cell function, Low risk of hypoglycemia
Indication: For Type-II Diabetic Mellitus, Increases insulin secretion, Improves B-cell function, Low risk of hypoglycemia
SITANOW-M 500
Composition:
Sitagliptin 50mg + Metformin Hydrochloride IP 500mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-M 1000
Composition:
Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-50
Composition:
Sitagliptin 50mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-100
Composition:
Sitagliptin 100mg
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
LINASUG-M 2.5/500
Composition:
Linagliptin 2.5 mg, Metformin Hydrochloride IP 500 mg
Indication: used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
Indication: used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
LINASUG-DP Tablet
Composition:
Linagliptin 5mg + Dapagliflozin 10mg
Indication: Used medications for the treatment of type-2 diabetes mellitus (T2DM)
Indication: Used medications for the treatment of type-2 diabetes mellitus (T2DM)
LINASUG-5
Composition:
Linagliptin 5 mg
Indication: used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
Indication: used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
DAPASUG-VD-100
Composition:
Dapagliflozin 10mg & Vildagliptin 100mg (Bilayered in Sustained Release Tablet)
Indication: TYPE 2 DIABETES
Indication: TYPE 2 DIABETES
DAPASUG-VD 50 (COMING SOON)
Composition:
Dapagliflozin 10mg + Vildagliptin 50mg
Indication: Diffuse the load of Diabetes before it Blast
Indication: Diffuse the load of Diabetes before it Blast
DAPASUG-VD 5/50 TABS
Composition:
Dapagliflozin 5mg + Vildagliptin 50mg
Indication: TYPE 2 DIABETES
Indication: TYPE 2 DIABETES
DAPASUG-TG 20
Composition:
Dapagliflozin 10mg + Teneligliptin 20mg
Indication: Ensure Victory in controlling Diabetes
Indication: Ensure Victory in controlling Diabetes
DAPASUG-ST-100
Composition:
Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg
Indication: A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes
Indication: A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes
DAPASUG-SM-500
Composition:
Dapagliflozin 10mg + Sitagliptin 100mg + Metformin (ER) 500mg
Indication: Treatment of Type 2 Diabetes mellitus
Indication: Treatment of Type 2 Diabetes mellitus
DAPASUG-SM 1000 TABLETS
Composition:
Dapagliflozin 10mg + Sitagliptin 100mg + Metformin Hydrochloride IP 1000mg (Extended Release)
Indication: Treatment of Type 2 Diabetes mellitus
Indication: Treatment of Type 2 Diabetes mellitus
DAPASUG-M
Composition:
Dapagliflozin 10mg + Metformin 500mg ER
Indication: Patients with heart failure with reduced ejection fraction, to reduce the risk of CV death and hospitalization for heart failure, Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
Indication: Patients with heart failure with reduced ejection fraction, to reduce the risk of CV death and hospitalization for heart failure, Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
ACARFIX-50
Composition:
Acarbose 50mg
Indication: A convenient and effective long-term option for the treatment of Type 2 Diabetes
Indication: A convenient and effective long-term option for the treatment of Type 2 Diabetes
ACARFIX-25
Composition:
Acarbose 25mg
Indication: A convenient and effective long-term option for the treatment of Type 2 Diabetes
Indication: A convenient and effective long-term option for the treatment of Type 2 Diabetes